-
1
-
-
0019410162
-
Alzheimer's disease: Evidence for selective loss of cholinergic neurons in the nucelus basalis
-
Whitehouse PJ, Price DL, Clarke AW, Coyle JT, DeLong MR. Alzheimer's disease: evidence for selective loss of cholinergic neurons in the nucelus basalis. Ann Neurol 1981; 10: 122-126.
-
(1981)
Ann Neurol
, vol.10
, pp. 122-126
-
-
Whitehouse, P.J.1
Price, D.L.2
Clarke, A.W.3
Coyle, J.T.4
DeLong, M.R.5
-
2
-
-
0027435345
-
Pharmacotherapy of Alzheimer's disease: New drugs and novel strategies
-
Giacobini E. Pharmacotherapy of Alzheimer's disease: new drugs and novel strategies. Prog Brain Res 1993; 98: 447-454.
-
(1993)
Prog Brain Res
, vol.98
, pp. 447-454
-
-
Giacobini, E.1
-
3
-
-
0029263518
-
Cholinergic therapies for Alzheimer's disease
-
Davis RE, Doyle PD, Carroll RT, Emmerling MR, Jaen J. Cholinergic therapies for Alzheimer's disease. Arzneimittelforschung 1995; 45: 425-431.
-
(1995)
Arzneimittelforschung
, vol.45
, pp. 425-431
-
-
Davis, R.E.1
Doyle, P.D.2
Carroll, R.T.3
Emmerling, M.R.4
Jaen, J.5
-
4
-
-
0011162190
-
Selective loss of central cholinergic neurons in Alzheimer's disease
-
Davis P, Maloney AJ. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976; ii: 1403.
-
(1976)
Lancet
, vol.2
, pp. 1403
-
-
Davis, P.1
Maloney, A.J.2
-
5
-
-
0020370303
-
Septal transplants restore maze learning in rats with fornixfimbria lesions
-
Dunnette SB, Low WC, Iversen SD, Stenevi U, Björklund A. Septal transplants restore maze learning in rats with fornixfimbria lesions. Brain Res 1982; 251: 335-348.
-
(1982)
Brain Res
, vol.251
, pp. 335-348
-
-
Dunnette, S.B.1
Low, W.C.2
Iversen, S.D.3
Stenevi, U.4
Björklund, A.5
-
6
-
-
0026551055
-
QSAR analysis of the substituted indanone and benzylpiperidine rings of a series of indanone-benzylpiperidine inhibitors of acetylcholinesterase
-
Cardozo MG, Iimura Y, Sugimoto H, Yamanishi Y, Hopfinger AJ. QSAR analysis of the substituted indanone and benzylpiperidine rings of a series of indanone-benzylpiperidine inhibitors of acetylcholinesterase. J Med Chem 1992; 35: 584-589.
-
(1992)
J Med Chem
, vol.35
, pp. 584-589
-
-
Cardozo, M.G.1
Iimura, Y.2
Sugimoto, H.3
Yamanishi, Y.4
Hopfinger, A.J.5
-
7
-
-
0026539070
-
Conformational analysis and molecular shape comparisons of a series of indanone-benzylpiperidine inhibitors of acetylcholinesterase
-
Cardozo MG, Kawai T, Iimura Y, Sugimoto H, Yamanishi Y, Hopfinger AJ. Conformational analysis and molecular shape comparisons of a series of indanone-benzylpiperidine inhibitors of acetylcholinesterase. J Med Chem 1992; 35: 590-601.
-
(1992)
J Med Chem
, vol.35
, pp. 590-601
-
-
Cardozo, M.G.1
Kawai, T.2
Iimura, Y.3
Sugimoto, H.4
Yamanishi, Y.5
Hopfinger, A.J.6
-
8
-
-
0026757043
-
Synthesis and anti-acetylcholinesterase activity of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine hydrochloride (E2020) and related compounds
-
Sugimoto H, Iimura Y, Yamanishi Y, Yamatsu K. Synthesis and anti-acetylcholinesterase activity of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine hydrochloride (E2020) and related compounds. Biorg Med Chem Lett 1992; 2: 871-876.
-
(1992)
Biorg Med Chem Lett
, vol.2
, pp. 871-876
-
-
Sugimoto, H.1
Iimura, Y.2
Yamanishi, Y.3
Yamatsu, K.4
-
9
-
-
0028710014
-
Prediction of the binding site of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine in acetylcholinesterase by docking studies with the SYSDOC program
-
Pang YP, Kozikowski AP. Prediction of the binding site of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine in acetylcholinesterase by docking studies with the SYSDOC program. J Comput Aided Mol Design 1994; 8: 683-693.
-
(1994)
J Comput Aided Mol Design
, vol.8
, pp. 683-693
-
-
Pang, Y.P.1
Kozikowski, A.P.2
-
10
-
-
0000396248
-
Inhibitory action of donepezil, a novel acetylcholinesterase inhibitor, on cholinesterase. Comparison with other inhibitors
-
eds Nagatsu T, Fisher A, Yoshida M. New York: Plenum Press
-
Yamanishi Y, Ogura H, Kosasa T, Araki S, Sawa Y, Yamatsu K. Inhibitory action of donepezil, a novel acetylcholinesterase inhibitor, on cholinesterase. Comparison with other inhibitors. In Basic, Clinical, and Therapeutic Aspects of Alzheimer's and Parkinson's Diseases, Volume 2, eds Nagatsu T, Fisher A, Yoshida M. New York: Plenum Press, 1990: 409-413.
-
(1990)
Basic, Clinical, and Therapeutic Aspects of Alzheimer's and Parkinson's Diseases
, vol.2
, pp. 409-413
-
-
Yamanishi, Y.1
Ogura, H.2
Kosasa, T.3
Araki, S.4
Sawa, Y.5
Yamatsu, K.6
-
11
-
-
0000557157
-
E2020 - The pharmacology of a piperidine cholinesterase inhibitor
-
eds Becker R, Giacobini E. Boston: Birkhäuser
-
Rogers SL, Yamanishi Y, Yamatsu K. E2020 - the pharmacology of a piperidine cholinesterase inhibitor. In Cholinergic Basis for Alzheimer Therapy, eds Becker R, Giacobini E. Boston: Birkhäuser, 1991: 314-320.
-
(1991)
Cholinergic Basis for Alzheimer Therapy
, pp. 314-320
-
-
Rogers, S.L.1
Yamanishi, Y.2
Yamatsu, K.3
-
12
-
-
0028316959
-
Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease
-
Watkins PB, Zimmerman HJ, Knapp MJ et al. Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease. JAMA 1994; 271: 992-998.
-
(1994)
JAMA
, vol.271
, pp. 992-998
-
-
Watkins, P.B.1
Zimmerman, H.J.2
Knapp, M.J.3
-
13
-
-
10244259208
-
The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a US multicenter, randomized, double-blind, placebo-controlled trial
-
Rogers SL, Friedhorff LT, the Donepezil Study Group. The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US multicenter, randomized, double-blind, placebo-controlled trial. Dementia 1996; 7: 293-303.
-
(1996)
Dementia
, vol.7
, pp. 293-303
-
-
Rogers, S.L.1
Friedhorff, L.T.2
-
14
-
-
0031883716
-
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
-
Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT, the Donepezil Study Group. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Neurology 1998; 50: 136-145.
-
(1998)
Neurology
, vol.50
, pp. 136-145
-
-
Rogers, S.L.1
Farlow, M.R.2
Doody, R.S.3
Mohs, R.4
Friedhoff, L.T.5
-
15
-
-
0031983322
-
Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: An interim analysis of the results of a US multicentre open-label extension study
-
Rogers SL, Friedhoff LT. Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open-label extension study. Eur Neuropsychopharmacol 1998; 8: 67-75.
-
(1998)
Eur Neuropsychopharmacol
, vol.8
, pp. 67-75
-
-
Rogers, S.L.1
Friedhoff, L.T.2
-
16
-
-
0032507788
-
Donepezil improves cognition and global function in Alzheimer's disease: A 15-week, double-blind, placebo-controlled study
-
Rogers SL, Doody RS, Mohs R, Friedhoff LT, the Donepezil Study Group. Donepezil improves cognition and global function in Alzheimer's disease: a 15-week, double-blind, placebo-controlled study. Arch Intern Med 1998; 158: 1021-1031.
-
(1998)
Arch Intern Med
, vol.158
, pp. 1021-1031
-
-
Rogers, S.L.1
Doody, R.S.2
Mohs, R.3
Friedhoff, L.T.4
-
17
-
-
0001346349
-
Validation and application of an HPLC method for the determination of 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl] methyl piperidine HCl (E2020) in human plasma
-
Lee JW, Rogers SL, Friedhoff, LT, Stiles MR, Cooper NM. Validation and application of an HPLC method for the determination of 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl] methyl piperidine HCl (E2020) in human plasma. Pharm Res 1992; 9: S350.
-
(1992)
Pharm Res
, vol.9
-
-
Lee, J.W.1
Rogers, S.L.2
Friedhoff, L.T.3
Stiles, M.R.4
Cooper, N.M.5
-
18
-
-
0344847655
-
A radioenzyme assay of acetylcholinesterase activity in red blood cells and its correlation with 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl] methyl piperidine HCl (E2020)
-
Hulse JD, Rogers SL, Friedhoff LT, Sukovaty R, Pedersen JE, Lee JW. A radioenzyme assay of acetylcholinesterase activity in red blood cells and its correlation with 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl] methyl piperidine HCl (E2020). Pharm Res 1992; 9: S338.
-
(1992)
Pharm Res
, vol.9
-
-
Hulse, J.D.1
Rogers, S.L.2
Friedhoff, L.T.3
Sukovaty, R.4
Pedersen, J.E.5
Lee, J.W.6
-
19
-
-
0025163917
-
Inhibitory action of E2020, a novel acetylcholinesterase inhibitor, on cholinesterase in aged rats
-
Yamanishi Y, Ogura H, Kosasa T et al. Inhibitory action of E2020, a novel acetylcholinesterase inhibitor, on cholinesterase in aged rats. Eur J Pharmacol 1990; 183: 1935.
-
(1990)
Eur J Pharmacol
, vol.183
, pp. 1935
-
-
Yamanishi, Y.1
Ogura, H.2
Kosasa, T.3
-
20
-
-
0032406418
-
Pharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral doses
-
Rogers SL, Cooper NM, Sukovaty R, Pederson JE, Lee JN, Friedhoff LT. Pharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral doses. Br J Clin Pharmacol 1998; 46 (Suppl. 1): 7-12.
-
(1998)
Br J Clin Pharmacol
, vol.46
, Issue.SUPPL. 1
, pp. 7-12
-
-
Rogers, S.L.1
Cooper, N.M.2
Sukovaty, R.3
Pederson, J.E.4
Lee, J.N.5
Friedhoff, L.T.6
-
21
-
-
0027141935
-
Comparison of the pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy young and elderly subjects
-
Ohnishi A, Mihara M, Kamakura H et al. Comparison of the pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy young and elderly subjects. J Clin Pharmacol 1993; 33: 1086-1091.
-
(1993)
J Clin Pharmacol
, vol.33
, pp. 1086-1091
-
-
Ohnishi, A.1
Mihara, M.2
Kamakura, H.3
-
22
-
-
0027230486
-
Pharmacokinetics of E2020 a new compound for Alzheimer's disease, in healthy male volunteers
-
Mihara M, Ohnishi A, Tomono Y et al. Pharmacokinetics of E2020 a new compound for Alzheimer's disease, in healthy male volunteers. Int J Clin Pharmacol Ther Toxicol 1993; 31: 223-229.
-
(1993)
Int J Clin Pharmacol Ther Toxicol
, vol.31
, pp. 223-229
-
-
Mihara, M.1
Ohnishi, A.2
Tomono, Y.3
|